Clinical Trials Logo

Tobacco Use Cessation clinical trials

View clinical trials related to Tobacco Use Cessation.

Filter by:

NCT ID: NCT03445507 Completed - Clinical trials for Tobacco Use Cessation

Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care.

Dej@lo
Start date: October 7, 2018
Phase: N/A
Study type: Interventional

This study aims to evaluate the effectiveness of an intervention to help people to quit smoking throughout an chat bot compared with usual assistance to increase long-term rates of nicotine abstinence in smoking outpatients with biochemical validation at 6 months. Half of participants(control group) will receive usual care by their usual general practitioners and nurses, and the other half (intervention group) will use an evidence-based chat bot specifically designed to help people quit smoking.

NCT ID: NCT03416621 Completed - Clinical trials for Tobacco Use Cessation

Project Q Pilot: Smoking Cessation for Light Smokers

Start date: May 17, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this pilot study is to evaluate the feasibility, acceptability, and preliminary efficacy of an intervention to promote smoking cessation among light smokers.

NCT ID: NCT03316495 Completed - Clinical trials for Tobacco Use Cessation

IMPACT OF PAMPHLET ON THE KNOWLEDGE OF HEALTH EFFECT OF SMOKING

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

Tobacco smoke is one of the most preventable cause of mortality and morbidity worlwide, this study is conducted to compare the knowledge of the health effects of smoking among undergraduates exposed and those not exposed to educational pamphlet. This is designed as a randomized clinical trial among 390 undergraduate in University of Benin Edo State Nigeria. Data collection tool was an interviewer-administered questionnaire. Data obtained would be subjected to regression statistics using IBM SPSS version 21.0. The expected outcome will be a veritable tool in tobacco cessation model.

NCT ID: NCT03259360 Completed - Smoking Cessation Clinical Trials

A Facebook Intervention for Young Sexual and Gender Minority Smokers

POP
Start date: April 23, 2018
Phase: N/A
Study type: Interventional

The 2-year research plan will test the Put It Out Project (POP) in a pilot randomized trial (N=120) compared to TSP and two historical control conditions. Participants will be young adults who smoke, identify as sexual or gender minorities, and use Facebook. The primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be a quit attempt (y/n), stage of change, and thoughts about tobacco abstinence at 3 and 6 mos.

NCT ID: NCT03238456 Completed - Smoking Cessation Clinical Trials

Smoking Cessation for Young Adult Pacific Islanders: Motivating Pacifika Against Cigarettes and Tobacco

MPACT
Start date: July 11, 2013
Phase: N/A
Study type: Interventional

The current study aimed to test a culturally tailored program designed to help Pacific Islanders (PIs) between the ages of 18 and 30 quit smoking cigarettes by using a randomized controlled trial design with one intervention group and one control group.

NCT ID: NCT03237949 Completed - Clinical trials for Tobacco Use Disorder

Text Messaging and Telephone Counseling for Supporting Post-discharge Quit Attempts

Start date: May 30, 2017
Phase: N/A
Study type: Interventional

This is an extension of a previous feasibility study (Clinical Trials Registry - NCT02571244). The actual study is a research aimed to compare the effectiveness of telephone counseling and personalized text messages (TM) for supporting post-discharge quit attempts among hospitalized smokers, with focus on smoking cessation as the main outcome. Smokers patients will receive brief interventions and nicotine replacement therapy during the hospitalization. After discharge smoker patients will be allocated into a intervention or control arm. In the first and third months, after randomization, the patients will be contact to smoke abstinence assessment.

NCT ID: NCT03227679 Completed - Tobacco Use Clinical Trials

Metabolism-informed Care for Smoking Cessation

Start date: May 18, 2016
Phase: N/A
Study type: Interventional

Nicotine mediates smoking's addictive effects in the brain. The ratio of 3-hydroxycotinine to cotinine, known as the nicotine metabolite ratio, or NMR, is a genetically- informed biomarker reflecting hepatic CYP2A6 activity and the rate of nicotine metabolism. In light of a recent randomized controlled trial (RCT) in humans in Lancet Respiratory Medicine, which found that the NMR can be used to individualize treatment for smokers, our pilot study aims to determine the feasibility of using NMR to guide selection of pharmacotherapy in clinical populations of daily smokers.

NCT ID: NCT03209557 Completed - Pregnancy Related Clinical Trials

Pilot Trial of Using SmokeBeat to Monitor and Increase Smoking Abstinence in Pregnant Women

Start date: July 5, 2017
Phase: N/A
Study type: Interventional

Investigators will assess the feasibility of implementing a randomized control trial of a behavioral intervention that uses smartwatch technology to monitor smoking behavior with texts aimed at reducing smoking in pregnant women who smoke. Investigators will compare the cessation rate of pregnant women who receive usual care through programs aimed at reducing smoking with pregnant women who receive usual care and are using the SmokeBeat app with a smartwatch.

NCT ID: NCT03194958 Completed - Smoking Cessation Clinical Trials

Helping Poor Smokers Quit

Start date: June 5, 2017
Phase: N/A
Study type: Interventional

Using a 2x2 randomized factorial design, we will conduct a statewide field trial in Missouri to compare the relative and combined effects of these two strategies for augmenting an existing, evidence-based tobacco quitline program. Among 2000 low-income smokers, half will receive standard Missouri quitline services and half will receive new Specialized Quitline services targeted to this group. In each of these groups, half also will receive calls from a trained navigator to help them address unmet Basic Needs and the accompanying psychological distress that act as barriers to smoking cessation.

NCT ID: NCT03168451 Completed - Clinical trials for Tobacco Use Cessation

American Indians STOp Smoking by Mobile Phone

AI STOMP
Start date: November 30, 2015
Phase: N/A
Study type: Interventional

In an attempt to reduce smoking-related health disparities, investigators will implement a text messaging-based smoking cessation intervention in collaboration with state quit lines. The approach is based on the successful STOMP (STOp smoking by Mobile Phone) program, a text messaging-based smoking cessation intervention among young Maori adults in New Zealand. Investigators will adapt the STOMP intervention, which will result in a new intervention known as AI STOMP (American Indians STOp smoking by Mobile Phone).The primary aim of the study is to determine the effectiveness of the AI-STOMP intervention in smoking cessation among American Indians.